Mindfulness-Based Cognitive Therapy: Efficacy and fMRI-based Response Predictors in a Group of OCD Patients
Obsessive-Compulsive Disorder
About this trial
This is an interventional treatment trial for Obsessive-Compulsive Disorder focused on measuring Obsessive-Compulsive Disorder, Mindfulness Based Intervention, Cognitive-Behavioral Therapy, Functional Magnetic Resonance Imaging, Neuropsychology, Childhood Maltreatment
Eligibility Criteria
Inclusion Criteria:
- Age frame: 18-50 years old.
- Principal Diagnosis: Obsessive compulsive disorder.
- Severity of OCD symptoms: between mild (Y-BOCS=9) and severe (Y-BOCS=32)
- Previous structured CBT or EPR, either in group or individual format, between 10 to 20 sessions.
- A maximum of three different pharmacological strategies.
- Minimum of IQ 85 measured by Vocabulary subtest (WAIS-IV).
- Minimum level of schooling: 14 years.
- To sign the informant consent.
Exclusion Criteria:
- Organic pathology and/or neurological disorders such as brain injury or epilepsy.
- Comorbidity with: Mental Retardation, previous or current substance abuse, psychotic disorders, bipolar disorder. Other affective and/or anxiety disorders will not be an exclusion criteria if OCD is considered the primary diagnosis.
- Recent suicide attempt/active suicidality
- Previous completion of an MBCT course (≥ 8 weeks)
Sites / Locations
- Corporacion Sanitaria Parc TaulíRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Mindfulness Based Intervention
Treatment as Usual (TAU)
Mindfulness-based cognitive therapy (MBCT), adjusted to OCD patients, will be applied in 10 weekly sessions of 2 hours followed by an extra session 4 weeks later. The treatment will be applied in a group format of 10 to 12 patients. These patients will be also attending to their regular psychiatric visits for medication control.
Patients will be attending to their regular psychiatric visits during the whole trial period.